Overview to recent commercial biosensors for diagnosis of cancers, cardiac diseases, and other diseases
Kitapta bölümler · 2020
Yazarlar: Kadriye Arzum ERDEM GÜRSAN, Ece Eksin, Muhammed Hüseyin ŞENTÜRK, Merve Uca
Commercial Biosensors and Their Applications: Clinical, Food, and Beyond, Elsevier, Uluslararası, 2020, ss 75-88, Amerika Birleşik Devletleri
DOI: 10.1016/B978-0-12-818592-6.00004-9
Özet
Laboratory analyzers are an invaluable resource but they have several limitations; for instance, they are more suited for a hospital setting and used by trained personnel who can operate the machine and interpret the results accurately. However, biosensors have many advantages, such as high sensitivity, rapid response, and user-friendly. It is essential to meet the necessities of IVD technologies in the market to establish biosensors developed for diagnosis of diseases. The demand for the accurate monitoring of biomarkers related to the most important fatal diseases is further driving forces for the development of novel analytical systems based on diagnostics. Thanks to the recent developments toward commercial biosensors, early diagnosis of diseases would significantly improve prognosis and survival rates by reducing disease burden, helping social development, and increasing life quality. This chapter is mainly focused on an overview of recent commercial biosensors developed for diagnosis of cancers, cardiac diseases, and other diseases.